card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Companion Diagnostics (CDx) A Central Laboratory Perspective

Companion Diagnostics (CDx) A Central Laboratory Perspective
Home / Insights / Companion Diagnostics (CDx) A Central Laboratory Perspective

In the June issue of Inside Precision Medicine, Alan Wookey, Vice President Companion Diagnostics and IQVIA Laboratories' scientific advisor, explores the evolution of companion diagnostics (CDx) since the landmark Herceptest approval in 1998.  Alan highlights how precision medicine has transformed patient care and the critical role of CDx in clinical trials and treatments. 

The article delves into CDx development paths, the impact of recent regulatory changes, and the future of precision medicine beyond oncology. Learn about the key considerations for successful CDx development and the latest advancements in diagnostic technology. 

Click here to read the full article.